Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis

Diana Ramirez Ardila; Mieke Timmermans; Jean Helmijr; John Martens; Els Berns; Maurice Jansen

doi:10.1016/j.tranon.2017.08.002

Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis

Diana Ramirez Ardila, Mieke Timmermans, Jean Helmijr, John Martens, Els Berns, Maurice Jansen

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Scopus)

45 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	854-867
Number of pages	14
Journal	Translational Oncology
Volume	10
Issue number	5
DOIs	https://doi.org/10.1016/j.tranon.2017.08.002
Publication status	Published - 2017

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.tranon.2017.08.002

REPUB_102136.pdfFinal published version, 2.24 MB

http://hdl.handle.net/1765/102136

Cite this

@article{6cb508168f2b4d93a4b131fa0927b1fb,

title = "Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis",

author = "{Ramirez Ardila}, Diana and Mieke Timmermans and Jean Helmijr and John Martens and Els Berns and Maurice Jansen",

year = "2017",

doi = "10.1016/j.tranon.2017.08.002",

language = "Undefined/Unknown",

volume = "10",

pages = "854--867",

journal = "Translational Oncology",

issn = "1936-5233",

publisher = "Neoplasia Press, Inc.",

number = "5",

}

TY - JOUR

T1 - Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis

AU - Ramirez Ardila, Diana

AU - Timmermans, Mieke

AU - Helmijr, Jean

AU - Martens, John

AU - Berns, Els

AU - Jansen, Maurice

PY - 2017

Y1 - 2017

U2 - 10.1016/j.tranon.2017.08.002

DO - 10.1016/j.tranon.2017.08.002

M3 - Article

C2 - 28886403

SN - 1936-5233

VL - 10

SP - 854

EP - 867

JO - Translational Oncology

JF - Translational Oncology

IS - 5

ER -